Scinai Immunotherapeutics Ownership | Who Owns Scinai Immunotherapeutics?

Scinai Immunotherapeutics Ownership Summary

Scinai Immunotherapeutics is owned by 8.09% institutional investors, 18.22% insiders, and 73.69% retail investors. State Street® SPDR® Ptf Dev Wld exUS ETF is the top mutual fund, with 0.00% of its assets in Scinai Immunotherapeutics shares.

SCNI Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Scinai Immunotherapeutics	8.09%	18.22%	73.69%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2024	12	9.09%	409,939	-11.35%	8	5.78%	5	-	2	-
Dec 31, 2023	11	22.22%	462,433	-24.72%	11	6.91%	5	-16.67%	2	-
Sep 30, 2023	9	-18.18%	614,306	179.14%	13	30.88%	6	200.00%	-	-100.00%
Jun 30, 2023	11	10.00%	220,069	-43.33%	6	4.53%	2	-50.00%	4	300.00%
Mar 31, 2023	10	-	388,321	60.43%	11	7.27%	4	-60.00%	1	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
State Street® SPDR® Ptf Dev Wld exUS ETF	2.00	0.00%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 28, 2005	BARRON PARTNERS LP	-	Sell	$251.77K
Sep 26, 2005	BARRON PARTNERS LP	-	Sell	$2.50K
Sep 23, 2005	BARRON PARTNERS LP	-	Sell	$2.55K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-
2005 Q3	-	3

SCNI Ownership FAQ

Who Owns Scinai Immunotherapeutics?

Scinai Immunotherapeutics shareholders are primarily institutional investors at 8.09%, followed by 18.22% insiders and 73.69% retail investors. The average institutional ownership in Scinai Immunotherapeutics's industry, Biotech Stocks , is 35.75%, which Scinai Immunotherapeutics falls below.

Does Blackrock own Scinai Immunotherapeutics?

BlackRock is not among the top 10 institutional shareholders of Scinai Immunotherapeutics.

Who is the top mutual fund holder of Scinai Immunotherapeutics shares?

State Street® SPDR® Ptf Dev Wld exUS ETF is the top mutual fund holder of Scinai Immunotherapeutics shares, with 0.00% of its total shares outstanding invested in 2 Scinai Immunotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools